Anbio Biotechnology (NNNN)
NASDAQ: NNNN · Real-Time Price · USD
7.27
-0.19 (-2.55%)
At close: Apr 1, 2025, 4:00 PM
7.21
-0.06 (-0.83%)
After-hours: Apr 1, 2025, 7:49 PM EDT

Anbio Biotechnology Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
10.319.697.14.18
Short-Term Investments
--1.57-
Cash & Short-Term Investments
10.319.698.674.18
Cash Growth
-2.38%11.75%107.33%-
Receivables
4.621.88-0.72
Inventory
--0.35-
Prepaid Expenses
3.844.174.920.02
Other Current Assets
0.01000
Total Current Assets
18.7715.7513.944.92
Property, Plant & Equipment
--0.01-
Long-Term Deferred Charges
0.160.04--
Other Long-Term Assets
0.020.020-
Total Assets
18.9415.8113.964.92
Accounts Payable
0.480.831.411.89
Accrued Expenses
0.020.13--
Other Current Liabilities
0.030.0300.49
Total Current Liabilities
0.530.991.412.38
Total Liabilities
0.530.991.412.38
Common Stock
0.010.01--
Additional Paid-In Capital
00--
Retained Earnings
18.414.812.552.54
Shareholders' Equity
18.4214.8212.552.54
Total Liabilities & Equity
18.9415.8113.964.92
Net Cash (Debt)
10.319.698.674.18
Net Cash Growth
-2.38%11.75%107.33%-
Net Cash Per Share
0.240.07--
Filing Date Shares Outstanding
42.2942.29--
Total Common Shares Outstanding
42.2942.29--
Working Capital
18.2414.7612.532.54
Book Value Per Share
0.440.35--
Tangible Book Value
18.4214.8212.552.54
Tangible Book Value Per Share
0.440.35--
Updated Dec 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q